LCS
AGN

Levin Capital Strategies’s Allergan Inc AGN Stock Holding History

Levin Capital Strategies’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-122,473
Closed -$26M – 451
2014
Q4 		$26M Buy
122,473
+11,766
+11% +$2.34M 0.39% 54
2014
Q3 		$19.7M Sell
110,707
-3,364
-3% -$559K 0.3% 67
2014
Q2 		$19.3M Buy
114,071
+111,571
+4,463% +$17.4M 0.3% 72
2014
Q1 		$310K Sell
2,500
-390,095
-99% -$47.5M 0.01% 288
2013
Q4 		$43.6M Sell
392,595
-148,481
-27% -$14.2M 0.7% 35
2013
Q3 		$48.9M Buy
+541,076
New +$48.6M 0.83% 33

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Levin Capital Strategies's AGN Position: Q1 2015 in Review

Levin Capital Strategies sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 122,473 shares — an estimated $26M sold.

Levin Capital Strategies first reported a position in AGN in Q3 2013 and held it in 6 quarters. The position peaked at $48.9M in Q3 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Levin Capital Strategies reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Levin Capital Strategies sold 122,473 Allergan Inc shares in Q1 2015, an estimated $26M.
  • Levin Capital Strategies first reported a position in Allergan Inc in Q3 2013 and held it in 6 quarters.
  • Levin Capital Strategies's Allergan Inc position peaked at $48.9M in Q3 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Levin Capital Strategies's 13F filing for Q1 2015, filed 12 May 2015.